Κυριακή 11 Μαρτίου 2018

A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours

A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours

A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours, Published online: 12 March 2018; doi:10.1038/s41416-018-0003-3

A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours

http://ift.tt/2FrUfsl

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου